This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Companies That Might Not Survive This Crisis

Jamba (JMBA - Get Report)

  • Market Cap: $55 Million
  • Z-Score: -0.82 (as of October 2008)
  • Jamba (better known as Jamba Juice) manufactures and retails blended juices, beverages and snacks, with an emphasis on freshness and nutrition. Unfortunately, Jamba Juice has had a lousy track record since going public in June 2005, at $8.00 per share. As with many "fad" companies, Jamba Juice's success was short-lived.

    Jamba has posted losses in six of the last eight quarters. Sales peaked in the company's first quarter of 2008 and have steadily declined since then.

    Why?

    Jamba's first problem is its lack of a full menu. Other than a few baked goods items, Jamba primarily serves juice and juice blends. That is not enough menu diversification to attract diners and generate growth.

    In its attempt to grow, Jamba has burned cash and has saddled itself with debt and lease obligations, which is the company's second problem. We should expect Jamba's cash burn and further balance sheet deterioration to continue.

    Finally, Jamba is about to feel pain from a new source: McDonald's (MCD - Get Report). On McDonald's last conference call the company emphasized that it will expand further into the beverage business -- specifically, smoothies, frappes and bottled drinks. This is one battle that McDonald's the Goliath will probably win.

    3 of 4

    Check Out Our Best Services for Investors

    Action Alerts PLUS

    Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

    Product Features:
    • $2.5+ million portfolio
    • Large-cap and dividend focus
    • Intraday trade alerts from Cramer
    Quant Ratings

    Access the tool that DOMINATES the Russell 2000 and the S&P 500.

    Product Features:
    • Buy, hold, or sell recommendations for over 4,300 stocks
    • Unlimited research reports on your favorite stocks
    • A custom stock screener
    Stocks Under $10

    David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

    Product Features:
    • Model portfolio
    • Stocks trading below $10
    • Intraday trade alerts
    14-Days Free
    Only $9.95
    14-Days Free
    Dividend Stock Advisor

    David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

    Product Features:
    • Diversified model portfolio of dividend stocks
    • Updates with exact steps to take - BUY, HOLD, SELL
    Trifecta Stocks

    Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

    Product Features:
    • Model Portfolio
    • Intra Day Trade alerts
    • Access to Quant Ratings
    Options Profits

    Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

    Product Features:
    • Actionable options commentary and news
    • Real-time trading community
    SYM TRADE IT LAST %CHG
    AAPL $132.54 0.88%
    AMD $2.28 0.00%
    GM $35.70 0.34%
    GILD $111.71 0.44%
    INTC $33.45 -0.30%

    Markets

    DOW 18,232.02 -53.72 -0.29%
    S&P 500 2,126.06 -4.76 -0.22%
    NASDAQ 5,089.3620 -1.4320 -0.03%

    Partners Compare Online Brokers

    Free Reports

    Top Rated Stocks Top Rated Funds Top Rated ETFs